Fulgent Genetics earnings were -$42.7M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest FLGT earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$5.9M, down 59.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, FLGT reported annual earnings of -$42.7M, with -74.6% growth. The next FLGT earnings date is May 1, 2025.
What were Fulgent Genetics's earnings last quarter?
On FLGT's earnings call on Invalid Date, Fulgent Genetics (NASDAQ: FLGT) reported Q4 2024 earnings per share (EPS) of -$0.19, up 95.58% year over year. Total FLGT earnings for the quarter were -$5.89 million. In the same quarter last year, Fulgent Genetics's earnings per share (EPS) was -$4.30.
The next FLGT earnings date is Invalid Date. Add FLGT to your watchlist to be reminded of Fulgent Genetics's next earnings date.
What was FLGT's earnings growth in the past year?
As of Fulgent Genetics's earnings date in Invalid Date, Fulgent Genetics's earnings has grown year over year. FLGT earnings in the past year totalled -$42.71 million.
Is Fulgent Genetics profitable or losing money?
As of the last Fulgent Genetics earnings report, Fulgent Genetics is currently losing money. Fulgent Genetics's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$42.71 million, a 74.55% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.